Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination of IAP inhibitors and FLT3 inhibitors

Combination of IAP inhibitors and FLT3 inhibitors

US Patent 8492429 · Granted Jul 23, 2013

Estimated economic value: $11,073,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Immunomodulation by IAP inhibitors2022
Compositions and methods for identification, assessment, prevention, and treatme2021
Immunomodulation by IAP inhibitors2020
Methods of predicting resistance to JAK inhibitor therapy2018
Immunomodulation by IAP inhibitors2017
Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic le2017
Pharmaceutical combination comprising co-administration of taxane and N-(1-cyclo2014
(S)-N-((S)-1-cyclohexyl-2-{(S)-2-[4-4-(4-fluorobenzoyl)-thiazol-2-yl]pyrrolidin-2013
SMAC peptidometics useful as IAP inhibitors2013
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activit2013
Inhibitors of IAP2012
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activit2012